🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Updated 04 Jul 2026 · HPRA open data

Janssen-Cilag International NV — Licensed Medicines

98 medicines held by Janssen-Cilag International NV on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 98 products held by Janssen-Cilag International NV
MedicineActive substanceLicence holderStatus
Akeega 100mg/500 mg Film-coated tablet
EU/1/23/1722/002
Niraparib Tosilate Monohydrate, Abiraterone acetate Janssen-Cilag International NV
Akeega 50 mg/500 mg Film-coated tablet
EU/1/23/1722/001
Niraparib Tosilate Monohydrate, Abiraterone acetate Janssen-Cilag International NV
Balversa 3 mg Film-coated tablet
EU/1/24/1841/001-004
Erdafitinib Janssen-Cilag International NV
Balversa 4 mg Film-coated tablet
EU/1/24/1841/005-009
Erdafitinib Janssen-Cilag International NV
Balversa 5 mg Film-coated tablet
EU/1/24/1841/010-011
Erdafitinib Janssen-Cilag International NV
BYANNLI 1 000 mg prolonged-release suspension for injection in pre-filled syringe
EU/1/20/1453/008
Paliperidone palmitate Janssen-Cilag International NV
BYANNLI 700 mg prolonged-release suspension for injection in pre-filled syringe
EU/1/20/1453/007
Paliperidone palmitate Janssen-Cilag International NV
Dacogen 50 mg powder for concentrate for solution for infusion
EU/1/12/792/001
Decitabine Janssen-Cilag International NV
DARZALEX 1800 mg solution for injection
EU/1/16/1101/004
Daratumumab Janssen-Cilag International NV
DARZALEX 20 mg/mL concentrate for solution for infusion
EU/1/16/1101/001-003
Daratumumab Janssen-Cilag International NV
EDURANT 2.5 mg film-coated tablets
EU/1/11/736/002
Rilpivirine Janssen-Cilag International NV
EDURANT 25 mg film-coated tablets
EU/1/11/736/001
Rilpivirine hydrochloride Janssen-Cilag International NV
Erleada 240 mg film-coated tablets
EU/1/18/1342/004-006
APALUTAMIDE Janssen-Cilag International NV
Erleada 60 mg film-coated tablets
EU/1/18/1342/001-003
APALUTAMIDE Janssen-Cilag International NV
IMBRUVICA 140 mg film-coated tablets
EU/1/14/945/007-008
Ibrutinib Janssen-Cilag International NV
IMBRUVICA 140 mg hard capsules
EU/1/14/945/001-002
Ibrutinib Janssen-Cilag International NV
IMBRUVICA 280 mg film-coated tablets
EU/1/14/945/009-010
Ibrutinib Janssen-Cilag International NV
IMBRUVICA 420 mg film-coated tablets
EU/1/14/945/005
Ibrutinib Janssen-Cilag International NV
IMBRUVICA 560 mg film-coated tablets
EU/1/14/945/006
Ibrutinib Janssen-Cilag International NV
Intelence 100 mg tablets
EU/1/08/468/1
Etravirine Janssen-Cilag International NV
Intelence 200 mg tablets
EU/1/08/468/002
Etravirine Janssen-Cilag International NV
Intelence 25 mg tablets
EU/1/08/468/003
Etravirine Janssen-Cilag International NV
INVEGA 12 mg prolonged-release tablets
EU/1/07/395/16-20
Paliperidone Janssen-Cilag International NV
INVEGA 3 mg prolonged-release tablets
EU/1/07/395/1-5
Paliperidone Janssen-Cilag International NV
INVEGA 6 mg prolonged-release tablets
EU/1/07/395/6-10
Paliperidone Janssen-Cilag International NV
INVEGA 9 mg prolonged-release tablets
EU/1/07/395/11-15
Paliperidone Janssen-Cilag International NV
Invokana 100 mg film-coated tablets
EU/1/13/884/001-004
Canagliflozin Janssen-Cilag International NV
Invokana 300 mg film-coated tablets
EU/1/13/884/005-008
Canagliflozin Janssen-Cilag International NV
Lazcluze 240 mg film-coated tablets
EU/1/24/1886/004-006
Lazertinib Janssen-Cilag International NV
Lazcluze 80 mg film-coated tablets
EU/1/24/1886/001-003
Lazertinib Janssen-Cilag International NV
Prezista
EU/1/06/380/003
Darunavir Janssen-Cilag International NV
Prezista
EU/1/06/380/006
Janssen-Cilag International NV
Prezista 150 mg film-coated tablets
EU/1/06/380/004
Darunavir (as ethanolate) Janssen-Cilag International NV
PREZISTA 600 mg film-coated tablets
EU/1/06/380/002
Darunavir (as ethanolate) Janssen-Cilag International NV
Prezista 75 mg film-coated tablets
EU/1/06/380/005
Darunavir (as ethanolate) Janssen-Cilag International NV
Prezista 800 mg film-coated tablet
EU/1/06/380/007
Darunavir (as ethanolate) Janssen-Cilag International NV
REKAMBYS 600 mg prolonged-release suspension for injection
EU/1/20/1482/001
Rilpivirine Janssen-Cilag International NV
REKAMBYS 900 mg prolonged-release suspension for injection
EU/1/20/1482/002
Rilpivirine Janssen-Cilag International NV
Remicade 100 mg Powder for concentrate for solution for infusion
EU/1/99/116/001-5
Infliximab Janssen-Cilag International NV
REZOLSTA 675 mg/150 mg film-coated tablets
EU/1/14/967/002
Darunavir ethanolate, Cobicistat Janssen-Cilag International NV
REZOLSTA 800 mg/150 mg film-coated tablets
EU/1/14/967/001
Darunavir, Cobicistat Janssen-Cilag International NV
Rybrevant 1 600 mg solution for injection
EU/1/21/1594/002
Amivantamab Janssen-Cilag International NV
Rybrevant 2240 mg solution for injection
EU/1/21/1594/003
Amivantamab Janssen-Cilag International NV
Rybrevant 350 mg concentrate for solution for infusion
EU/1/21/1594/001
Amivantamab Janssen-Cilag International NV
Simponi 100 mg solution for injection in pre-filled pen
EU/1/09/546/005-008
Golimumab Janssen-Cilag International NV
Simponi 45 mg/0.45 mL solution for injection in pre-filled pen.
EU/1/09/546/009
Golimumab Janssen-Cilag International NV
Simponi 50 mg solution for injection in pre-filled pen
EU/1/09/546/1-4
Golimumab Janssen-Cilag International NV
SIRTURO 100 mg tablets
EU/1/13/901/001
Bedaquiline fumarate Janssen-Cilag International NV
SIRTURO 20 mg tablets
EU/1/13/901/003
Bedaquiline fumarate Janssen-Cilag International NV
Spravato 28 mg nasal spray, solution
EU/1/19/1410/001-004
ESKETAMINE HYDROCHLORIDE, Esketamine Janssen-Cilag International NV
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.